VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19
Written by newsfeed
VIC Foundry’s innovative designs for a low-cost at-home COVID-19 test Funding for the project is being provided by the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Tech program to support new approaches to nationwide COVID-19 testing and surveillance ALBUQUERQUE, N.M. (PRWEB) February 16, 2021 This diagnostic technology uses Sandia’s patented QUASR (Quenching of Unincorporated Amplification Signal Reporters) assay with sequence-specific fluorescence detection, combined with VIC Foundry’s innovative designs for a low-cost test cartridge and monitor.